These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 4746119)

  • 1. Problems of the severely burnt patient.
    Allgöwer M
    Bull Soc Int Chir; 1973; 32(3):287-9. PubMed ID: 4746119
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunotherapy of burns--animal experiments].
    Sauer D; Sauer H; Böhland W
    Z Exp Chir; 1982 Oct; 15(5):303-9. PubMed ID: 7157899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunotherapy as a pathogenetic treatment method in burns (experimental justification)].
    Fedorov NA; Movshev BE; Nedoshivina RV; Koriakina IK
    Patol Fiziol Eksp Ter; 1982; (6):30-40. PubMed ID: 6185912
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study of the toxic properties of normal and burnt skin in mice with block of the reticuloendothelial system].
    Fedorov NA; Nedoshivina RV; Movshev BE
    Biull Eksp Biol Med; 1972 Jan; 73(1):28-30. PubMed ID: 5011186
    [No Abstract]   [Full Text] [Related]  

  • 5. [New findings on burn toxins and their practical application].
    Städtler K; Cueni L; Donatsch P; Schoenenberger GA
    Ther Umsch; 1971 Dec; 28(12):847-50. PubMed ID: 5158875
    [No Abstract]   [Full Text] [Related]  

  • 6. [Burn disease--effect of toxin or consequence of infection?].
    Schoenenberger GA; Städtler K; Burkhart F; Müller W; Zellner P
    Chirurg; 1974 Jan; 45(1):20-8. PubMed ID: 4823122
    [No Abstract]   [Full Text] [Related]  

  • 7. [Problems of burn toxins].
    Schoenenberger GA
    Praxis; 1969 Sep; 58(37):1153-4. PubMed ID: 5820316
    [No Abstract]   [Full Text] [Related]  

  • 8. [Development of treatment for burns].
    Lorthioir J
    Brux Med; 1970 Nov; 50(11):905-7. PubMed ID: 5510577
    [No Abstract]   [Full Text] [Related]  

  • 9. Isolation, activity, and physicochemical characterization of a burn toxin from mouse skin.
    Schoenenberger GA; Allgöwer M
    Br J Surg; 1969 Sep; 56(9):704. PubMed ID: 5808420
    [No Abstract]   [Full Text] [Related]  

  • 10. Fractions of middle molecular weight responsible for immunodeficiency in malnourished and burnt patients.
    Gay G; Touraine JL; Touraine F; Freyria AM; Traeger J; Navarro J
    Artif Organs; 1981; 4 Suppl():71-5. PubMed ID: 6794551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Toxicity of burned skin high molecular weight protein according to the results of biological experiments in vivo and in vitro].
    Movshev BE; Nedoshivina RV; Koriakina IK
    Biull Eksp Biol Med; 1980 Oct; 90(10):422-5. PubMed ID: 7426703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic effectiveness of gamma-globulin on experimental burns].
    Movshev BE; Nedoshivina RV; Koriakina IK
    Biull Eksp Biol Med; 1982 Jun; 93(6):52-5. PubMed ID: 6180781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anesthesia in severely burnt patients: a 10-year experience].
    D'Eramo C; Grattagliano C; Lombardelli L
    Cah Anesthesiol; 1994; 42(5):657-60. PubMed ID: 7728616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunological and immunotherapeutic studies on the model of mice following thermic injury ].
    Sauer H; Sauer D; Ambrosius H
    Allerg Immunol (Leipz); 1981; 27(3):176-87. PubMed ID: 6181672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The future care of the burnt patient in Ireland. An investigation and report.
    Brady DO; Edwards GE
    Ir Med J; 1976 Nov; 69(19):514-5. PubMed ID: 1002423
    [No Abstract]   [Full Text] [Related]  

  • 16. [Some problems of transfusion therapy in the severely burned patient].
    Guzeev VA
    Vestn Khir Im I I Grek; 1970 Mar; 104(3):71-5. PubMed ID: 5505932
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-Pseudomonas immunoglobulin. IV. Combined anti-Pseudomonas immunoglobulin and Pseudomonas vaccine immunotherapy of burned patients--clinical investigations.
    Sakiel S; Schiller B; Buchowicz I; Lysakowska E; Tomanek E; Kruczałowa M; Przewdziecka M
    Arch Immunol Ther Exp (Warsz); 1984; 32(5):523-8. PubMed ID: 6534319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacteriostatic and biological stimulation effect of Mepitel on experimental burns on the skin of rats.
    Troshev K; Kolev Z; Zlateva A; Shishkov S; Pashaliev N; Raycheva-Mutafova E
    Acta Chir Plast; 1997; 39(3):97-102. PubMed ID: 9439012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Advances in the treatment of the critically burnt patient].
    Arévalo JM; Lorente JA
    Med Clin (Barc); 1999 Dec; 113(19):746-53. PubMed ID: 10680128
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of skin bank in the treatment of severely burnt patients.
    Dvoránková B; Broz L; Pafcuga I; Kapounková Z; Königová R
    Acta Chir Plast; 2004; 46(2):51-5. PubMed ID: 15462066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.